Effect of volatile anesthetics on early and delayed outcomes in pancreas transplantation

• Published in: Clinical transplantation 2021-02, Vol.35 (2), p.e14153-n/a
• Main Authors: Atoa, Sam M., Mangus, Richard S., Graham, Ryan C., Kroepfl, Elizabeth A., Powelson, John A., Fridell, Jonathan A.
• Format: Article
• Language: English
• Subjects: anesthesia; inhaled anesthetic agents; ischemia‐reperfusion injury; pancreas transplantation; transplant outcomes
• ISSN: 0902-0063; 1399-0012
• DOI: 10.1111/ctr.14153

Background Ischemia‐reperfusion injury (IRI) is a common cause of allograft dysfunction and patient morbidity in solid organ transplantation. This study compares the effect of different inhaled anesthetics on early IRI and clinical outcomes in pancreas allograft recipients. Methods Data were extracted retrospectively for pancreas transplants at a single center over a 15‐year period. Early postoperative pancreatic amylase and lipase levels were used as a marker for graft injury. Clinical outcomes measured included length of hospital stay, readmission, and graft survival. Results There were 625 pancreas transplants included in the analysis with 3 primary inhaled anesthetics: sevoflurane (53%), desflurane (35%), and isoflurane (12%). In the first 30 days post‐transplant, peak amylase was lowest for sevoflurane (147) followed by desflurane (159) and isoflurane (229) (p = .03). Peak lipase levels followed the same trend (peak values 118, 131, and 135, respectively; p = .02). Early graft loss, length of hospital stay, and readmission within 3 months were similar among all three anesthetic groups. There was no difference in 10‐year graft survival by Cox regression. Conclusions Sevoflurane and desflurane are associated with lower peak amylase and lipase levels postoperatively in pancreas transplantation. Short‐ and long‐term clinical outcomes were equivalent for the three agents.